DOI: 10.1055/s-00035024

Thrombosis and Haemostasis


Glund S, Stangier J, Schmohl M. et al.
Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.

Lancet 2015;
386: 680-690.

Download Bibliographical Data

Search in: